Trevi Therapeutics, Inc. (TRVI)

Typically moves ±5.33% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-11 ESTIMATED

Across 31 earnings reports since Jun 14, 2019, Trevi Therapeutics, Inc. (TRVI) has a clear post-earnings pattern. It moves ±5.33% on average after reporting and finishes higher 54.8% of the time. Its largest post-earnings gain was +48.32% (Mar 16, 2020) and its largest decline was -8.97% (May 07, 2024). The next earnings report is predicted for 2026-11-11 (estimated).

Earnings reactions

How TRVI moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.33%

Positive %

54.8%

Negative %

45.2%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☽ POST	+0.11%	open_in_new
May 05, 2026	☽ POST	-2.46%	open_in_new
Apr 17, 2026	☀ PRE	+4.75%	open_in_new
Mar 17, 2026	☽ POST	-4.47%	open_in_new
Nov 13, 2025	☽ POST	-0.79%	open_in_new
Aug 07, 2025	☽ POST	+1.64%	open_in_new
May 08, 2025	☽ POST	+0%	open_in_new
Mar 18, 2025	☽ POST	+3.81%	open_in_new
Nov 06, 2024	☽ POST	-6.45%	open_in_new
Aug 08, 2024	☽ POST	+2.14%	open_in_new
May 07, 2024	☽ POST	-8.97%	open_in_new
Mar 20, 2024	☽ POST	+4.52%	open_in_new
Nov 09, 2023	☽ POST	-3.32%	open_in_new
Aug 10, 2023	☽ POST	-0.42%	open_in_new
May 11, 2023	☽ POST	-5.67%	open_in_new
Mar 16, 2023	☽ POST	-1.1%	open_in_new
Nov 10, 2022	☽ POST	+1.04%	open_in_new
Aug 11, 2022	☽ POST	-3.75%	open_in_new
May 12, 2022	☽ POST	+7.8%	open_in_new
Mar 17, 2022	☽ POST	+9.8%	open_in_new
Nov 10, 2021	☽ POST	+0.85%	open_in_new
Aug 12, 2021	☽ POST	-4.05%	open_in_new
May 13, 2021	☽ POST	+2.49%	open_in_new
Mar 25, 2021	☽ POST	+7.54%	open_in_new
Nov 12, 2020	☀ PRE	-8.28%	open_in_new
Aug 13, 2020	☽ POST	+3.53%	open_in_new
May 07, 2020	☽ POST	-0.56%	open_in_new
Mar 16, 2020	☀ PRE	+48.32%	open_in_new
Nov 14, 2019	☽ POST	+7.87%	open_in_new
Aug 12, 2019	☽ POST	-7.14%	open_in_new
Jun 14, 2019	☽ POST	+1.46%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.33%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 25 →

Funds holding

$443280802

Total value held

Buying

20 added · 5 reduced

Blackrock, Inc.

$208041234 +8.93%

State Street Corp

$56459425 +13.58%

Raymond James Financial Inc

$30388753 -7.12%

Bank Of America Corp /De/

$28588381 +25.96%

Goldman Sachs Group Inc

$22426998 -2.06%

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
S-8	20260806	open_in_new SEC.gov
SCHEDULE 13G/A	20260806	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
8-K	20260604	open_in_new SEC.gov

Frequently asked about TRVI earnings

When does Trevi Therapeutics, Inc. report earnings next? expand_more

Trevi Therapeutics, Inc. (TRVI)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TRVI stock move after earnings? expand_more

Over 31 reports, TRVI has moved an average of ±5.33% the session after earnings, closing higher 54.8% of the time.

What was TRVI's biggest post-earnings move? expand_more

TRVI's largest post-earnings gain on record was +48.32% on Mar 16, 2020, and its largest decline was -8.97% on May 07, 2024.

Where can I find Trevi Therapeutics, Inc.'s SEC filings? expand_more

All of Trevi Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.